Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
A phase 3 trial of Somatostatin receptor PET in Neuroendocrine tumours, run by Radiomedix, Inc., completed.
Overview
Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE is a phase 3 interventional study registered as NCT03673943 by Radiomedix, Inc., with 63 participants recorded, started 2018-08-23 and reaching its primary completion in 2019-03-23. Interventions recorded: 64Cu-DOTATATE. Conditions recorded: Neuroendocrine Tumors.
Linked to the technology Somatostatin receptor PET because the registry names it ("64cu dotatate") among its interventions and Neuroendocrine tumours among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialDual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
Shares Somatostatin receptor PET (68Ga/64Cu-DOTATATE), Neuroendocrine tumours and the tag pipeline.
- TrialA Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Shares Neuroendocrine tumours and the tag pipeline.
- Trial68Ga-DOTA-TATE PET/CT Imaging in NETs
Shares Neuroendocrine tumours and the tag pipeline.
- TrialTelotristat With Lutathera in Neuroendocrine Tumors
Shares Neuroendocrine tumours and the tag pipeline.
- TrialA Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Shares Neuroendocrine tumours and the tag pipeline.
- TrialA Study of PM8002 in Combination With Chemotherapy in Patients With NEN
Shares Neuroendocrine tumours and the tag pipeline.
- TrialA Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms
Shares Neuroendocrine tumours and the tag pipeline.
- TrialDose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Shares Neuroendocrine tumours and the tag pipeline.